Pharma Lab CRO ApS: Financial statements 2023
CVR: 40729364
Source: annual report 2023, Danish Business Authority
01/01/2023 – 31/12/2023
Pharma Lab CRO ApS (CVR 40729364) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK -2,086,073 and a net result of DKK -2,114,659 compared with DKK 42,586 the year before. Equity in the 2023 report amounted to DKK 142,319. The solvency ratio was 0.7%. The company had 2 employees in the financial year.
- Gross Profit
- DKK -2,086,073
- Profit/Loss
- DKK -2,114,659
- Equity
- DKK 142,319
- Total Assets
- DKK 20,153,025
- Employees
- 2
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2023 | - | -2.1M | -2.1M | 142K | 2 |
| 2022 | - | 1.6M | 43K | 2.3M | 2 |
| 2021 | - | 2.4M | 1.8M | 2.2M | 1 |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record, straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
Pharma Lab CRO ApS has published its annual report for 2022. Gross profit came to DKK 1,648,274, and the net result was DKK 42,586.
About Pharma Lab CRO ApS
Pharma Lab CRO ApS is a Danish company of the type Anpartsselskab based in Hvidovre, founded in 2019. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Jakob Juul Rasmussen. The company is owned by JaJR Holding 2 ApS. The company has 1 employee (2026). In 2025, the company reported a gross profit of DKK 1,665,168 and a net result of DKK -299,305 compared with DKK 117,249 the year before. Equity in the 2025 report amounted to DKK -5,311,766.